Site Search

... in who is benefiting from biomarker testing and biomarker-informed treatment. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it,” said Bryte Johnson, ACS CAN Connecticut director of government relations.   “There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. Already, 20 states have passed similar laws to increase access to comprehensive biomarker testing—and it’s time for ...